| All patients | Without postoperative complications | With postoperative complications | P value |
---|---|---|---|---|
(n = 923) | (n = 666) | (n = 257) | ||
Demographic data | ||||
 Age, year | 73.5 ± 6.2 | 73.3 ± 6.1 | 74.1 ± 6.3 | 0.092 |
 Female gender | 347 (37.6%) | 243 (36.5%) | 104 (40.5%) | 0.263 |
 Body mass index |  |  |  | 0.049 |
   < 18.5 kg/m2 | 58 (6.3%) | 33 (5.0%) | 25 (9.7%) |  |
  18.5–23.9 kg/m2 | 467 (50.6%) | 347 (52.1%) | 120 (46.7%) |  |
  24–27.9 kg/m2 | 315 (34.1%) | 227 (34.1%) | 88 (34.2%) |  |
   ≥ 28 kg/m2 | 83 (9.0%) | 59 (8.9%) | 24 (9.3%) |  |
General status | ||||
 ASA class |  |  |  | < 0.001 |
  I | 7 (0.8%) | 5 (0.8%) | 2 (0.8%) |  |
  II | 537 (58.2%) | 430 (64.6%) | 107 (41.6%) |  |
  III | 361 (39.1%) | 225 (33.8%) | 136 (52.9%) |  |
  IV | 18 (2.0%) | 6 (0.9%) | 12 (4.7%) |  |
 Modified frailty index |  |  |  | < 0.001 |
  0.00 | 220 (23.8%) | 177 (26.6%) | 43 (16.7%) |  |
  0.09 | 284 (30.8%) | 221 (33.2%) | 63 (24.5%) |  |
  0.18 | 194 (21.0%) | 139 (20.9%) | 55 (21.4%) |  |
  0.27 | 117 (12.7%) | 75 (11.3%) | 42 (16.3%) |  |
  0.36 | 75 (8.1%) | 41 (6.2%) | 34 (13.2%) |  |
  0.45 | 23 (2.5%) | 9 (1.4%) | 14 (5.4%) |  |
  0.55 | 7 (0.8%) | 3 (0.5%) | 4 (1.6%) |  |
  0.64 | 3 (0.3%) | 1 (0.2%) | 2 (0.8%) |  |
 Malnutritiona | 212 (23.0%) | 128 (19.2%) | 84 (32.7%) | < 0.001 |
Comorbidities and history b | ||||
 Asthma | 19 (2.1%) | 13 (2.0%) | 6 (2.3%) | 0.714 |
 Obstructive sleep apnea c | 42 (4.6%) | 19 (2.9%) | 23 (8.9%) | < 0.001 |
 Severe arrhythmia d | 77 (8.3%) | 48 (7.2%) | 29 (11.3%) | 0.045 |
 Other cardiac diseases e | 24 (2.6%) | 15 (2.3%) | 9 (3.5%) | 0.285 |
 Mental disorders f | 21 (2.3%) | 14 (2.1%) | 7 (2.7%) | 0.570 |
 Major neurodegenerative diseases g | 16 (1.7%) | 7 (1.1%) | 9 (3.5%) | 0.023 |
 Visual/hearing impairment | 31 (3.4%) | 18 (2.7%) | 13 (5.1%) | 0.075 |
 Chronic renal insufficiency h | 31 (3.4%) | 17 (2.6%) | 14 (5.4%) | 0.029 |
 Chronic hepatic dysfunction i | 49 (5.2%) | 27 (4.1%) | 22 (8.2%) | 0.006 |
 Hyper−/hypothyroidism | 19 (2.1%) | 14 (2.1%) | 5 (1.9%) | 0.881 |
 Chronic corticosteroid therapy j | 26 (2.8%) | 16 (2.4%) | 10 (3.9%) | 0.220 |
 Malignant tumor | 741 (80.3%) | 514 (77.2%) | 227 (88.3%) | < 0.001 |
 Current smoker/quit ≤4 weeks k | 134 (14.5%) | 93 (14.0%) | 41 (16.0%) | 0.442 |
 Current alcoholism/quit ≤4 weeks l | 42 (4.6%) | 28 (4.2%) | 14 (5.4%) | 0.417 |
Laboratory tests | ||||
 Hemoglobin < 90 g/L | 82 (8.9%) | 41 (6.2%) | 41 (16.0%) | < 0.001 |
 Albumin ≤30 g/L | 44 (4.8%) | 20 (3.0%) | 24 (9.3%) | < 0.001 |
 Na+ < 135.0 mmol/L | 116 (12.6%) | 81 (12.2%) | 35 (13.6%) | 0.550 |
 Ca++ < 2.1 mmol/L | 32 (3.5%) | 21 (3.2%) | 11 (4.3%) | 0.402 |
 K+ < 3.5 or > 5.5 mmol/L | 99 (10.7%) | 70 (10.5%) | 29 (11.3%) | 0.734 |
Composite risk index m |  |  |  | < 0.001 |
 0 | 502 (54.4%) | 413 (62.0%) | 89 (34.6%) |  |
 1 | 306 (33.2%) | 196 (29.4%) | 110 (42.8%) |  |
 2 | 92 (10.0%) | 50 (7.5%) | 42 (16.3%) |  |
  ≥ 3 | 23 (2.5%) | 7 (1.1%) | 16 (6.2%) |  |
Intraoperative data | ||||
 Type of surgery |  |  |  | < 0.001 |
  Simple general surgeries n | 80 (8.7%) | 77 (11.6%) | 3 (1.2%) |  |
  Gastric | 154 (16.7%) | 100 (15.0%) | 54 (21.0%) |  |
  Intestinal | 556 (60.2%) | 414 (62.2%) | 142 (55.3%) |  |
  Hepatopancreatobiliary | 133 (14.4%) | 75 (11.3%) | 58 (22.6%) |  |
 Surgery by Operative Stress Score o |  |  |  | < 0.001 |
  Low stress | 56 (6.1%) | 55 (8.3%) | 1 (0.4%) |  |
  Moderate stress | 266 (28.8%) | 215 (32.3%) | 51 (19.8%) |  |
  High stress | 526 (57.0%) | 357 (53.6%) | 169 (65.8%) |  |
  Very high stress | 75 (8.1%) | 39 (5.9%) | 36 (14.0%) |  |
 Duration of surgery, hour | 3.2 (2.4, 4.3) | 3.0 (2.3, 4.0) | 3.6 (2.6, 5.0) | < 0.001 |
 Type of anesthesia |  |  |  | 0.346 |
  General | 448 (48.5%) | 321 (48.2%) | 127 (49.4%) |  |
  Combined PNB-general | 438 (47.5%) | 322 (48.3%) | 116 (45.1%) |  |
  Combined epidural-general | 32 (3.5%) | 19 (2.9%) | 13 (5.1%) |  |
  Neuraxial | 5 (0.5%) | 4 (0.6%) | 1 (0.4%) |  |
 Seniority of anesthesiologists |  |  |  | 0.490 |
   < 5 years | 259 (28.0%) | 194 (29.1%) | 65 (25.3%) |  |
  5 to 10 years | 175 (19.0%) | 123 (18.5%) | 52 (20.2%) |  |
   > 10 years | 489 (53.0%) | 349 (52.4%) | 140 (54.5%) |  |
 Blood transfusion | 64 (6.9%) | 33 (5.0%) | 31 (12.1%) | < 0.001 |
 Estimated blood loss, ml | 100 (50, 200) | 50 (50, 150) | 100 (50, 200) | < 0.001 |
Postoperative data | ||||
 Postoperative complications p | 257 (27.8%) | – | 257 (100.0%) | – |
 Clavien-Dindo classification q |  |  |  | – |
  Grade II | 160 (17.3%) | – | 160 (62.3%) |  |
  Grade III | 33 (3.6%) | – | 33 (12.8%) |  |
  Grade IV | 57 (6.2%) | – | 57 (22.2%) |  |
  Grade V | 7 (0.8%) | – | 7 (2.7%) |  |
 ICU admission | 236 (25.6%) | 106 (15.9%) | 130 (50.6%) | < 0.001 |
  LOS in ICU, hour | 24.0 (18.0, 48.0) | 20.0 (16.0, 24.0) | 41.0 (20.0, 91.0) | < 0.001 |
 Unplanned reintubation | 12 (1.3%) | 0 (0%) | 12 (4.7%) | < 0.001 |
 Unplanned reoperation | 28 (3.0%) | 0 (0%) | 28 (10.9%) | < 0.001 |
 Hospital LOS, day | 16.0 (14.0, 21.0) | 15.0 (13.0, 19.0) | 21.0 (16.0, 29.0) | < 0.001 |
  Hospital LOS after surgery, day | 10.0 (8.0, 12.0) | 9.0 (7.0, 10.0) | 13.0 (11.0, 20.0) | < 0.001 |
 Adverse discharge destination r | 15 (1.6%) | 0 (0%) | 15 (5.8%) | < 0.001 |